Pfizer (PFE) EBITDA Margin (2009 - 2026)
Pfizer (PFE) posted EBITDA Margin of 39.16% for Q2 2026, down 6.41 percentage points from 45.57% a year earlier and down 9.04 percentage points from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) EBITDA Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 28, 2026, EBITDA Margin at Pfizer was 42.35%, up 0.25 percentage points year-over-year; for FY2025, it came in at 43.66%, up 4.66 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of +2.94 percentage points (FY2020 to FY2025).
- In prior years, Pfizer's EBITDA Margin was 39.01% in FY2024 (+18.02 pp), 20.98% in FY2023 (-23.90 pp), 44.89% in FY2022 (+5.78 pp) and 39.11% in FY2021 (-1.61 pp).
- Quarterly EBITDA Margin has run from a low of -8.79% in Q4 2023 to a high of 51.25% in Q2 2022 over five years.
- On a year-over-year basis, EBITDA Margin increased in five of the last seven quarters, with an average year-over-year change of +7.89 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2024, with a gain of 40.23 percentage points; the weakest was Q2 2023, with a drop of 12.93 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 48.20% (Q1 2026), 34.17% (Q4 2025) and 48.79% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 7.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 39.16% |
| Mar 29, 2026 | 48.20% |
| Dec 31, 2025 | 34.17% |
| Sep 28, 2025 | 48.79% |
| Jun 29, 2025 | 45.57% |
| Mar 30, 2025 | 47.95% |
| Dec 31, 2024 | 31.45% |
| Sep 29, 2024 | 45.41% |
| Jun 30, 2024 | 30.46% |
| Mar 31, 2024 | 48.03% |
| Dec 31, 2023 | -8.79% |
| Jul 2, 2023 | 38.32% |
| Apr 2, 2023 | 49.81% |
| Jul 3, 2022 | 51.25% |
| Apr 3, 2022 | 45.90% |
| Oct 3, 2021 | 38.35% |
| Jul 4, 2021 | 42.62% |
| Apr 4, 2021 | 46.66% |
| Dec 31, 2020 | 28.56% |
| Sep 27, 2020 | 44.03% |
API Access
Pfizer EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();